Justice Department charges 78 people with $2.5 billion in health-care fraud

Justice Department charges 78 people with .5 billion in health-care fraud


U.S. Attorney General Merrick Garland speaking on June 22, 2023 in Washington, DC.

Chip Somodevilla | Getty Images

The Justice Department on Wednesday charged 78 people with $2.5 billion in health-care fraud.

The DOJ, in a press release, said the defendants allegedly defrauded programs used to take care of elderly and disabled people. In some cases, they used the money to buy luxury cars, jewelry and yachts, according to the agency.

The allegations include charges against 11 defendants of submitting $2 billion in fraudulent claims through telemedicine, as well as charges against 10 defendants in connection with fraudulent prescription drug claims.

The defendants include “physicians and other licensed medical professionals who lined their own pockets, including doctors who allegedly put their patients at risk by illegally providing them with opioids they did not need,” the DOJ release reads.

“These enforcement actions, including against one of the largest health care fraud schemes ever prosecuted by the Justice Department, represent our intensified efforts to combat fraud and prosecute the individuals who profit from it,” said Attorney General Merrick Garland in a statement.

CNBC Health & Science

Read CNBC’s latest health coverage:

This is a developing story. Please check back for updates.



Source

Medical supply firm Medline set to debut after biggest IPO of 2025
Health

Medical supply firm Medline set to debut after biggest IPO of 2025

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year.  The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the […]

Read More
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly
Health

Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly

Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1 pills for obesity are closer than ever.  2026 is likely the year that two new oral weight loss […]

Read More
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Health

Pfizer’s modest 2026 outlook shows its big investments will take time to pay off

Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs. Those hurdles aren’t surprising or new for Pfizer, which has seen a dramatic decline in Covid vaccine and antiviral sales […]

Read More